Blog

Research • August 1, 2026

BPC-157 is a synthetic peptide investigated in preclinical research environments for its molecular interactions, cellular signaling pathways, and biological activity.

Research • August 1, 2026

Retatrutide is an investigational triple receptor agonist studied for its interaction with GLP-1, GIP, and glucagon pathways in advanced metabolic research.

Research • August 1, 2026

Semaglutide is a long-acting GLP-1 receptor agonist extensively studied in metabolic research, providing valuable insights into glucose regulation, peptide stability, and hormone signaling pathways.